Two-dose Rituximab as Effective as Standard 4 in Severe AAV

Two-dose Rituximab as Effective as Standard 4 in Severe AAV

300632

Two-dose Rituximab as Effective as Standard 4 in Severe AAV

A two-dose rituximab regimen is as safe and works as well as the standard four doses in inducing remission in adults with severe granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), according to a review study. While these findings support the current use of either regimen in clinical practice for treating GPA and MPA — two types of ANCA-associated vasculitis (AAV) — they highlight that patients may equally benefit from a two-dose regimen that’s more convenient…

You must be logged in to read/download the full post.